These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1864575)

  • 41. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ; Doller JC
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
    Jalenques I; Coudert AJ
    Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do anticonvulsants hinder clozapine treatment?
    Wilson WH
    Biol Psychiatry; 1995 Jan; 37(2):132-3. PubMed ID: 7718678
    [No Abstract]   [Full Text] [Related]  

  • 45. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.
    Buchanan RW; Kirkpatrick B; Bryant N; Ball P; Breier A
    Am J Psychiatry; 1996 Dec; 153(12):1625-7. PubMed ID: 8942462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Schizophrenia, affective symptoms and clozapine].
    Meynard JA; Bernadet R; Sanchez MF; Morel P
    Encephale; 1995 Jun; 21 Spec No 3():41-7. PubMed ID: 7628341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.
    Revicki DA; Luce BR; Weschler JM; Brown RE; Adler MA
    Hosp Community Psychiatry; 1990 Aug; 41(8):850-4. PubMed ID: 2169457
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 49. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 50. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detecting improvement in quality of life and symptomatology in schizophrenia.
    Cramer J; Rosenheck R; Xu W; Henderson W; Thomas J; Charney D;
    Schizophr Bull; 2001; 27(2):227-34. PubMed ID: 11354590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine.
    Tollefson GD; Birkett MA; Kiesler GM; Wood AJ;
    Biol Psychiatry; 2001 Jan; 49(1):52-63. PubMed ID: 11163780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolonged psychotic relapse after abrupt clozapine withdrawal.
    Parsa MA; al-Lahham YH; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1993 Apr; 13(2):154-5. PubMed ID: 8463447
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial.
    León CA
    Acta Psychiatr Scand; 1979 May; 59(5):471-80. PubMed ID: 380268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neopterin and biopterin CSF levels in tardive dyskinesia after clozapine treatment.
    Fleischhacker WW; Levine RA; Lieberman JA; Pollack S; Johns CA; Richardson MA
    Biol Psychiatry; 1993 Nov; 34(10):741-5. PubMed ID: 8292676
    [No Abstract]   [Full Text] [Related]  

  • 60. Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
    Sacchetti E; Galluzzo A; Valsecchi P; Romeo F; Gorini B; Warrington L;
    Schizophr Res; 2009 May; 110(1-3):80-9. PubMed ID: 19269791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.